Tu2029 GASTRIC BYPASS SURGERY FOR TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE IN OBESE PATIENTS WITH BMI > 30

2020 ◽  
Vol 158 (6) ◽  
pp. S-1593
Author(s):  
WILLY PETRINI SOUZA ◽  
ANA CAROLINA ANDRADE CANUT ◽  
FERNANDO F. NUNES ◽  
Bruno Zilberstein
2016 ◽  
Vol 263 (1) ◽  
pp. 110-116 ◽  
Author(s):  
Carlos Augusto S. Madalosso ◽  
Richard Ricachenevsky Gurski ◽  
Sidia M. Callegari-Jacques ◽  
Daniel Navarini ◽  
Guilherme Mazzini ◽  
...  

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 63-63
Author(s):  
Marcin Migaczewski ◽  
Mateusz Rubinkiewicz ◽  
Michał Pędziwiatr ◽  
Piotr Major ◽  
Jadwiga Dworak ◽  
...  

Abstract Background Laparoscopic Roux-en-Y gastric bypass (LRYGB) has been proved to be effective bariatric procedure for the treatment of morbidly obese patients with gastroesophageal reflux disease (GERD). In contrast, the indication for laparoscopic sleeve gastrectomy (LSG) in these group of patients is still not clear. LSG with simultaneous crural repair it can be a new, safe and effective therapautic approach. Methods A total of 60 obese patients with GERD operated on in 2016–2018 were included in the study. 20 patients were qualified for LRYBG. In the rest LSG was performed, of which half with simultaneous crural repair. Results GERD symptoms complete control was observed in 18/20 (90%) patients after LRYGB and 17/20 (85%) after LSG with simultaneous crural repair. The same effect occurred only in 8/20 patients direct after simple LSG. ‘De novo’ GERD symptoms developed in 10% of the patients undergoing alone LSG during 12 months follow up. Conclusion Laparoscopic Roux-en-Y gastric bypass (LRYGB) is still effective bariatric procedure for the treatment of morbidly obese patients with gastroesophageal reflux disease (GERD). Doubts remain in the situation of young patients without diabetes. If we additionally deal with a large hiatal hernia, the qualification for LRYGB remains debatable. In this situation, it is worth considering LSG. Simple sleeve gastrectomy not only does not guarantee a good anti-reflux effect, but it can also produce de-novo GERD. Laparoscopic simultanous crurolasty in the time of LSG, represents a valuable option for the treatment of morbid obesity with gastroesophageal reflux disease Disclosure All authors have declared no conflicts of interest.


2009 ◽  
Vol 136 (5) ◽  
pp. A-740
Author(s):  
Carlos Augusto S. Madalosso ◽  
Fernando Fornari ◽  
Flavia Boff ◽  
Fernando Balestreri ◽  
Richard R. Gurski

2020 ◽  
Vol 11 (4) ◽  
pp. 134-139
Author(s):  
Robin Mauricio Yance Hurtado ◽  
Thiago Ferreira de Souza ◽  
Manoel dos Passos Galvão Neto ◽  
Eduardo Grecco ◽  
Sergio A Barrichello Junior ◽  
...  

2017 ◽  
Vol 1 (1) ◽  
Author(s):  
Flores Edgar Vargas ◽  
Cortez Juan Carlos Quintana ◽  
Contreras Jose Luis Ledesma ◽  
Medina Yazmin Berrones ◽  
Zhou Lucero Chao

Sign in / Sign up

Export Citation Format

Share Document